ENDRA Life Sciences's total assets for Q2 2024 were $10.44M, an increase of 106.35% from the previous quarter. NDRA total liabilities were $1.45M for the fiscal quarter, a 6.32% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.